Scilife

What Scilife does

Scilife is a Pakistan-based pharmaceutical company headquartered in Karachi that manufactures and markets branded generic pharmaceutical products. Founded in 2008, the company operates as a private for-profit entity with a workforce in the 1,001-5,000 employee range, placing it among the larger mid-market players in Pakistan's domestic pharmaceutical sector.

The company's core business is the production and commercialization of branded generics — off-patent pharmaceutical molecules sold under proprietary brand names — which is the dominant business model in Pakistan's pharma industry. No further details on product portfolio, therapeutic areas, manufacturing facilities, technology stack, or proprietary formulations are available in the provided source material; the company's own website (scilife.biz) returned only a loading/verification page at the time of data collection, and the only other source was an unrelated news article about Novartis Pharma Pakistan.

Scilife's revenue model, pricing approach, customer mix, distribution channels, partnerships, and capital structure are all undocumented in the available sources. The company is privately held (no IPO or public ticker), has no disclosed parent company, subsidiaries, or funding rounds, and carries no disclosed management team or leadership information in the input data. This represents a substantial information gap for any investor conducting due diligence on the company.

Name

Scilife

Website

https://scilife.biz

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Scilife is a Karachi-based, privately held pharmaceutical company founded in 2008 that manufactures and markets branded generic pharmaceutical products, with a workforce of 1,001-5,000 employees serving the Pakistan pharmaceutical market.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Branded generic pharmaceuticals
• Pharmaceutical manufacturing
• Generic drug products
• Pharmaceutical marketing
• Finished dosage manufacturing

Headquarters

HQ city

Karachi

HQ country

Pakistan

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Core offering

Scilife manufactures and markets branded generic pharmaceutical products. The company is a Pakistan-based pharmaceutical producer operating in the generics segment, producing and commercializing finished dosage pharmaceutical formulations under its own brand names.

Product overview

No product or service information available in the source data. The sources provided do not contain substantive content about Scilife's product offerings, portfolio, or services.

Differentiator

Problem solved

Functional benefit

Products and services

• Branded Generic Pharmaceutical Products

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Broad incumbents

• Cipla:
• Abbott Laboratories Pakistan: Subsidiary of global pharma major operating in Pakistan. Competes across branded generics and innovator segments with broader portfolio and stronger regulatory resources.
• GSK Pakistan: Multinational pharma subsidiary selling branded prescription and consumer health products in Pakistan. Overlaps with Scilife in primary care branded generics and has a much larger international parent.
• Aurobindo Pharma: Emerging-market-export-oriented generics major. Useful benchmark for export-formulation strategy, regulatory dossier investments, and emerging-market pricing that Scilife would need to follow to scale beyond Pakistan.

Direct peers

• Getz Pharma: Pakistan's largest branded-generics manufacturer, headquartered in Karachi. Directly comparable in business model (branded generics), therapeutic breadth, and export orientation.
• Hilton Pharma: Karachi-based branded generics and specialty pharma company. Comparable in scale, local manufacturing footprint, and target customer base (physicians, hospitals, pharmacies) in Pakistan.
• Searle Pakistan: Listed Pakistani pharma manufacturer with a branded-generics portfolio across multiple therapeutic areas. Closely matched on business model and domestic market positioning.
• Highnoon Laboratories: Karachi-headquartered branded generics manufacturer with export operations. Comparable on formulation capabilities, headcount scale, and Pakistan-centric distribution.
• Ferozsons Laboratories: Listed Pakistani branded-generics company with branded licensing partnerships (e.g., Boehringer Ingelheim). Comparable as a domestic manufacturer competing in the same therapy areas and channels.

Regional players

• English Pharma: Karachi-based local generics manufacturer serving Pakistan. Mid-tier peer for assessing competitive intensity and pricing pressure in the same geographic market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/ScilifeP
• Facebookfacebook.com/Scilife.Official
• LinkedInlinkedin.com/company/scilife-pharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scilife